Compile Data Set for Download or QSAR
Report error Found 28 Enz. Inhib. hit(s) with all data for entry = 930
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299214BDBM299214(US10125148, Example 11)
Affinity DataEC50:  3nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299215BDBM299215(US10125148, Example 12)
Affinity DataEC50:  3nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299217BDBM299217(US10125148, Example 13)
Affinity DataEC50:  4nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299229BDBM299229(US10125148, Example 23 | US10125148, Example 24)
Affinity DataEC50:  4nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299231BDBM299231(US10125148, Example 25)
Affinity DataEC50:  4nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299211BDBM299211(US10125148, Example 8)
Affinity DataEC50:  5nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299212BDBM299212(US10125148, Example 9)
Affinity DataEC50:  6nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299224BDBM299224(US10125148, Example 18)
Affinity DataEC50:  7nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299219BDBM299219(US10125148, Example 15)
Affinity DataEC50:  8nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299222BDBM299222(US10125148, Example 16)
Affinity DataEC50:  8nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299218BDBM299218(US10125148, Example 14)
Affinity DataEC50:  9nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299223BDBM299223(US10125148, Example 17)
Affinity DataEC50:  9nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299213BDBM299213(US10125148, Example 10)
Affinity DataEC50:  11nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299228BDBM299228(US10125148, Example 22)
Affinity DataEC50:  13nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299208BDBM299208(US10125148, Example 5)
Affinity DataEC50:  22nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299206BDBM299206(US10125148, Example 4)
Affinity DataEC50:  23nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299229BDBM299229(US10125148, Example 23 | US10125148, Example 24)
Affinity DataEC50:  24nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299204BDBM299204(US10125148, Example 2)
Affinity DataEC50:  26nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299205BDBM299205(US10125148, Example 3)
Affinity DataEC50:  26nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299234BDBM299234(US10125148, Example 28n.d.)
Affinity DataEC50:  27nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299210BDBM299210(US10125148, Example 7)
Affinity DataEC50:  29nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299209BDBM299209(US10125148, Example 6)
Affinity DataEC50:  31nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299225BDBM299225(US10125148, Example 19)
Affinity DataEC50:  33nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299203BDBM299203(US10125148, Example 1)
Affinity DataEC50:  39nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299233BDBM299233(US10125148, Example 27)
Affinity DataEC50:  45nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299232BDBM299232(US10125148, Example 26)
Affinity DataEC50:  49nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299226BDBM299226(US10125148, Example 20)
Affinity DataEC50:  133nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1)
Viiv Healthcare UK (NO.5)

US Patent
LigandChemical structure of BindingDB Monomer ID 299227BDBM299227(US10125148, Example 21)
Affinity DataEC50:  150nMAssay Description:Inhibition of HIV replication. A recombinant NL-Rluc virus was constructed in which a section of the nef gene from NL4-3 was replaced with the Renill...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/12/2019
Entry Details
US Patent